Delving into the Latest Updates on BBM-C101 with Synapse

Overview

Basic Info

Drug Type

AAV based gene therapy

Synonyms

BBM C101

Target-

Action-

Mechanism-

Therapeutic Areas

NeoplasmsInfectious DiseasesUrogenital Diseases

Active Indication

Infectious DiseasesCervical Intraepithelial NeoplasiaUterine Cervical Cancer+ [1]

Inactive Indication-

Originator Organization

Belief BioMed, Inc.

Active Organization

Shanghai Mianyi Biotechnology Co., Ltd.Belief BioMed, Inc.

Inactive Organization-

License Organization-

Drug Highest PhasePhase 1/2

First Approval Date-

Regulation-

Login to view timeline

I期研究主要目的：评价BBM-C101注射液单药疗法在组织学证实的HPV16和/或HPV18感染相关子宫颈HSIL（子宫颈上皮内瘤变(Cervical Intraepithelial Neoplasia, CIN)2级[CIN2]或3级[CIN3]）的成年女性参与者中皮下注射给药的安全性和耐受性。 IIa期研究目的：评价BBM-C101注射液在组织学证实的HPV16和/或HPV18感染相关的子宫颈HSIL成年女性参与者中的初步有效性。

[Translation]

The primary objective of the Phase I study was to evaluate the safety and tolerability of subcutaneous administration of BBM-C101 injection monotherapy in adult female participants with histologically confirmed HPV16 and/or HPV18 infection-associated cervical HSIL (cervical intraepithelial neoplasia (CIN) grade 2 [CIN2] or 3 [CIN3]). The objective of the Phase IIa study was to evaluate the preliminary efficacy of BBM-C101 injection in adult female participants with histologically confirmed HPV16 and/or HPV18 infection-associated cervical HSIL.

Start Date-

Sponsor / Collaborator

Shanghai Mianyi Biotechnology Co., Ltd.

100 Clinical Results associated with BBM-C101

Login to view more data

100 Translational Medicine associated with BBM-C101

Login to view more data

100 Patents (Medical) associated with BBM-C101

Login to view more data

100 Deals associated with BBM-C101

Login to view more data

R&D Status

10 top R&D records.

Login

to view more data

Indication	Highest Phase	Country/Location	Organization	Date
Infectious Diseases	Phase 2	China	Shanghai Mianyi Biotechnology Co., Ltd.	15 Jun 2026
Cervical Intraepithelial Neoplasia	Phase 2	China	Belief BioMed, Inc.	-
Uterine Cervical Cancer	Phase 2	China	Belief BioMed, Inc.	-
Squamous Intraepithelial Lesions of the Cervix	IND Approval	China	Shanghai Mianyi Biotechnology Co., Ltd.	26 Nov 2025